Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Familial Cancer
Published in: Familial Cancer 2/2005

01-06-2005

Informing one’s family about genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a retrospective exploratory study

Authors: Ilse Mesters, Marlein Ausems, Sophie Eichhorn, Hans Vasen

Published in: Familial Cancer | Issue 2/2005

Login to get access
Metadata
Title
Informing one’s family about genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a retrospective exploratory study
Authors
Ilse Mesters
Marlein Ausems
Sophie Eichhorn
Hans Vasen
Publication date
01-06-2005
Publisher
Kluwer Academic Publishers
Published in
Familial Cancer / Issue 2/2005
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-004-7992-1

Other articles of this Issue 2/2005

Familial Cancer 2/2005 Go to the issue

OriginalPaper

The Tyr978X BRCA1 mutation: occurrence in non-Jewish Iranians and haplotype in French-Canadian and non-Ashkenazi Jews

OriginalPaper

SISE matters: the Sum of Information on Seventy-yr-old Equivalents measures pedigree information content when assessing the risk of HNPCC in a family

OriginalPaper

Abdominal desmoid in familial adenomatous polyposis presenting as a pancreatic cystic lesion

OriginalPaper

Referrals of patients to colorectal cancer genetics services in south-east Scotland

OriginalPaper

Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients

OriginalPaper

Screening for exonic copy number mutations at MSH2 and MLH1 by MAPH
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits